Viral vectors for enhanced ultrasound-mediated delivery to the brain
OwnerJerzy O. Szablowski, Hongyi Li +2inventors
InventorsJerzy O. Szablowski, Hongyi Li, John E. Heath, Mikhail G. Shapiro
Life of this patent
Estimating the term…
Loading patent…
OwnerJerzy O. Szablowski, Hongyi Li +2inventors
InventorsJerzy O. Szablowski, Hongyi Li, John E. Heath, Mikhail G. Shapiro
Estimating the term…
Disclosed herein include adeno-associated virus (AAV) acoustic targeting peptides. An AAV comprising the AAV acoustic targeting peptide can exhibit increased transduction at site(s) of focused ultrasound blood-brain barrier opening (FUS-BBBO), increased neuronal tropism, and diminished transduction of peripheral organs. Disclosed herein include recombinant adeno-associated virus (rAAV) comprising an AAV acoustic targeting peptide disclosed herein. Also provided herein include methods of delivering an agent to one or more target brain region(s) of a subject.
An adeno-associated virus (AAV) acoustic targeting peptide comprising an amino acid sequence that comprises at least 4 contiguous amino acids from a sequence selected from the group consisting of AGNTSDR (SEQ ID NO:
A method of delivering an agent to one or more target brain region(s) of a subject, the method comprising:
A method of treating or preventing a disease or disorder in a subject in need thereof, comprising:
Dependencies are inferred from the claim text.